Who are French Lyophilized Plasma's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/french-lyophilized-plasma.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

French Lyophilized Plasma — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

French Lyophilized Plasma (French Lyophilized Plasma) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Plasma product / Hemostatic agent. Area: Hematology / Hemostasis / Critical Care.

phase 3 Plasma product / Hemostatic agent Hematology / Hemostasis / Critical Care Biologic Live · refreshed every 30 min

Target snapshot

French Lyophilized Plasma (French Lyophilized Plasma) — French Defence Health Service. French Lyophilized Plasma replaces clotting factors and other plasma proteins to restore hemostatic function in patients with coagulopathy or massive hemorrhage.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
French Lyophilized Plasma TARGET	French Lyophilized Plasma	French Defence Health Service	phase 3	Plasma product / Hemostatic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Plasma product / Hemostatic agent class)

French Defence Health Service · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). French Lyophilized Plasma — Competitive Intelligence Brief. https://druglandscape.com/ci/french-lyophilized-plasma. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing